Bextra Stroke

A Bextra stroke is a possible side effect of taking this popular prescription painkiller. A Bextra stroke is just one of the many serious and potentially deadly side effects that prompted the FDA to request a recall of this drug. On April 7, 2005, Pfizer took its blockbuster painkiller, Bextra, off the market because the risks associated with Bextra far outweigh the drug's intended benefits.

Bextra stroke, heart attack, and fatal skin condition risks were among the most serious side effects which prompted the Bextra recall. Bextra enjoyed about a three year stay on the market before being pulled from the shelves, yet knowledge of its serious side effects began surfacing soon after its 2001 FDA approval. As early as 2002, the FDA requested that Pfizer add stronger warnings to its Bextra labeling about serious skin side effects. Bextra use has been associated with Stevens Johnson syndrome, a deadly drug reaction that devastates the skin and mucous membranes and can lead to death if not properly treated.

Concern about Bextra stroke and heart attack risks first came to the fore of social concern after a similar drug was recalled because of its cardiovascular risks. Vioxx, also a COX-2 selective non-steroidal anti-inflammatory drug, was voluntarily pulled from the shelves by its maker in September 2004. The Vioxx recall was prompted by clinical studies which found that patients taking Vioxx for eighteen months doubled their risk of suffering a heart attack or stroke.

After the Vioxx recall, Pfizer made several public announcements indicating that these risks were unique to Vioxx. Bextra stroke and heart attack risks, Pfizer claimed, were no greater than the cardiovascular risks posed to the general population. Less than two months later, however, Pfizer was forced to contradict this statement. In December 2004, researchers concluded that patients who took Bextra following heart surgery were two times more likely to suffer a Bextra stroke, heart attack, blood clot, or other significant cardiac event as compared to those trial participants not taking Bextra.

Despite this evidence of Bextra stroke and heart attack risks, Pfizer made no indication of any plans to recall their defective drug or strengthen warning labels. In response to Bextra stroke and heart attack risks, the FDA urged doctors to limit their use of Bextra and look to alternatives for prescription pain relief. The FDA and other regulatory agencies ordered a review of all Bextra clinical trials to further evaluate Bextra stroke and heart attack risks. After comprehensive investigation, the FDA determined that Bextra stroke, heart attack, and skin risks were too great to allow this drug to remain on the market.

Many Bextra users have suffered serious side effects like Bextra stroke, heart attack, or skin conditions because Pfizer failed to adequately inform and protect consumers.

If you or a loved one has suffered a Bextra stroke or any other adverse side effect of this drug, please contact a Bextra Recall Lawyer at the Montgomery Law Firm regarding Bextra stroke related illnesses.

Do I have a Bextra Case?

If you believe that you or a loved one has been adversely affected by Bextra, please fill out the form below. There is no charge for this Bextra case evaluation.

Free Bextra Stevens Johnson Syndrome Case Evaluation

Please fill out the form below to have your case evaluated.

Please provide as much information as possible about your case. If you do not provide adequate case information, including injuries or damages sustained it may take us longer to process your inquiry.

*Items are required.
There is no charge for this evaluation.

Contact Information:

*Title: *First Name: MI: *Last Name:
 
*E-mail Address:
Home Phone:
- -
Mobile Phone: - -
Work Phone: - - ext.
  *Provide at least 1 phone number.
*Street Address:
Apt/Suite:
*City:
*State/Zip: /
 
What is the best way to reach you?
Please provide the best place, time and method for contacting you.
 
Additional Contact Information:
Use this area to add country codes, foreign addresses, special instructions, etc.

Injured Person Information:

Date of Birth:
Whom are you inquiring on behalf of?
If you are NOT inquiring on your own behalf,
what is your relationship?
Is the person deceased? Yes No

If deceased, the cause of death
as stated on the death certificate: 

Date of Death:
Was there an autopsy performed? Yes  No  n/a
Did you take Bextra within 2 weeks of your injury? Yes  No

Case Information:

During what period of time was Bextra prescribed?
Start End

Why was Bextra prescribed?

What dosage of Bextra were you prescribed daily?

List names/addresses of any doctors who prescribed Bextra:

Did effects from Bextra include:

Stevens Johnson Syndrome Yes No
Heart Attack Yes No
Stroke Yes No
Deep Vein Thrombosis Yes No
Blood Clots Yes No
Pulmonary Embolism Yes No
Death Yes No

Other medical problems since Bextra usage:

Date medical problem(s) first occurred:

Other Information:

Disclaimers:

Yes No - I agree that this matter may be referred to an attorney in my area who may contact me.

Yes No - I agree that by submitting this question, I will not be charged for the initial response. I understand that I am forming only a semi-confidential relationship.

Yes - I agree that the above does not constitute a request for legal advice and that I am not forming an attorney client relationship by submitting this question. I understand that I may only retain an attorney by entering into a fee agreement, and that I am not hereby entering into a fee agreement. I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Since this matter may require advice regarding my home state, I agree that local counsel may be contacted for referral of this matter.

By Clicking the appropriate box below, I agree to:

Security Image
For purposes of security, please type the letters from above in the space provided.